The effect of hypobaric hypoxia on misonidazole binding in normal and tumour-bearing mice

M P MacManus, A P Maxwell, W P Abram, J M Bridges

Research output: Contribution to journalArticlepeer-review

17 Citations (Scopus)


The effect of hypobaric hypoxia on the in vivo binding of misonidazole was investigated in normal mice and mice bearing T50/80 or CA NT mammary carcinomas. After the intraperitoneal injection of radiolabelled misonidazole, mice were randomised to breathe either room air or air at 0.5 atmospheres. The distribution of misonidazole in liver, kidney, heart, spleen and tumour tissue, 24 h later, was studied by scintillation counting and by autoradiography. Significantly higher misonidazole binding occurred in the livers (x2.5), kidneys (x2.4), spleens (x2.9) and hearts (x1.8) of hypoxic mice compared to controls. Hypobaric hypoxia was associated with a greater than four-fold increase in misonidazole binding within T50/80 tumours. However, significantly higher binding was not demonstrated within CA NT tumours after exposure of tumour-bearing animals to hypoxic conditions. In autoradiographs of hypoxic liver, labelling was intense in regions near to hepatic veins but sparse in areas surrounding portal tracts. This pattern was striking and consistent. In hypoxic kidney, labelling was most intense over tubular cells, less intense over glomeruli and sparse in the renal medulla. It is likely that the hepatic and renal cortical distributions of misonidazole binding reflect local oxygen gradients.
Original languageEnglish
Pages (from-to)349-52
Number of pages4
JournalBritish Journal of Cancer
Issue number3
Publication statusPublished - 1989


Dive into the research topics of 'The effect of hypobaric hypoxia on misonidazole binding in normal and tumour-bearing mice'. Together they form a unique fingerprint.

Cite this